Therefore, augmentation of the MMEJ activity was recognized as one of the mechanisms underlying PARPi resistance in BRCA1/2-mutated cancer cells6, and targeting the MMEJ activity by inhibiting Polθ was considered a means to sensitize cancer cells to PARPi. This evidence concerns the gene BRCA1 and cancer.